Elite Pharmaceuticals, Inc. (ELTP) Announces New Management Appointees
Elite Pharmaceuticals, a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, today reported new appointments to key management positions. Dr. Kennedy Smith, J.D., M.B.A. joins Elite as Vice President of Legal; Dr. Jason LePree as Vice President of Scientific Affairs; and Dr. Sophy Abraham as Vice President of Regulatory Affairs. "We are pleased to welcome Ken, Jason, and Sophy to the Elite team and I'm thrilled with the caliber of expertise that these individuals bring to Elite," said Nasrat Hakim, Elite's President and Chief Executive Officer. "These additions greatly strengthen our management team in key…